TrialCritical care (London, England)2022

Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial.

Antoine Monsel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.